Aptose Biosciences, Inc.
APTO
APTO was delisted on the 1st of April, 2025.
12 hedge funds and large institutions have $3.67M invested in Aptose Biosciences, Inc. in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 0 closing their positions.
33% more funds holding
Funds holding: 9 → 12 (+3)
44% less capital invested
Capital invested by funds: $6.53M → $3.67M (-$2.87M)
83% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$23.7K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$16.2K |
| 3 |
Jane Street
New York
|
+$14.9K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.25K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$202K |
| 2 |
Franklin Resources
San Mateo,
California
|
-$129K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$8.09K |
| 4 |
Morgan Stanley
New York
|
-$4.98K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.25K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Franklin Resources
San Mateo,
California
| $1.78M | -$129K | -207 | -7% |
|
|
CAM
2
Cormorant Asset Management
Boston,
Massachusetts
| $1.38M | – | – | – |
|
|
BBA
3
Baker Bros. Advisors
New York
| $359K | -$202K | -324 | -36% |
|
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| $45K | +$16.2K | +26 | +57% |
|
|
5
Bank of Montreal
Toronto,
Ontario, Canada
| $41K | -$8.09K | -13 | -12% |
|
|
TSS
6
Two Sigma Securities
New York
| $24K | +$23.7K | +38 | New |
|
|
7
Jane Street
New York
| $15K | +$14.9K | +24 | New |
|
|
8
Morgan Stanley
New York
| $8K | -$4.98K | -8 | -40% |
|
|
9
Bank of America
Charlotte,
North Carolina
| $7K | -$1.25K | -2 | -15% |
|
10
UBS Group
Zurich,
Switzerland
| $2K | – | – | – |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| $2K | +$1.25K | +2 | New |
|
12
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $1K | -$622 | -1 | -25% |
|
|
SIM
13
Sonora Investment Management
Tucson,
Arizona
| – | -$18 | – | – |
|
APTO Hedge Fund Activity: Q4 2016 in Review
12 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Aptose Biosciences, Inc. (APTO) for Q4 2016, worth a combined $3.67M — down 44% from $6.53M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new APTO positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 6 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $23.7K. The largest seller was Baker Bros. Advisors, cutting an estimated $202K.
- 12 institutional investors held Aptose Biosciences, Inc. (APTO) as of Q4 2016, up from 9 in Q3 2016.
- Funds reported $3.67M of Aptose Biosciences, Inc. stock for Q4 2016, down 44% quarter-over-quarter.
- 3 funds opened new Aptose Biosciences, Inc. positions in Q4 2016 and 0 closed out, a net change of +3 holders.
- The largest Aptose Biosciences, Inc. buyer in Q4 2016 was Two Sigma Securities, an estimated $23.7K added.
- The largest Aptose Biosciences, Inc. seller in Q4 2016 was Baker Bros. Advisors, an estimated $202K sold.
Based on aggregated 13F filings for Q4 2016.